Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
742
+2
+0.3% +$685 0.17% 75
2026
Q1
$260K Buy
740
+1
+0.1% +$356 0.19% 70
2025
Q4
$242K Buy
739
+2
+0.3% +$634 0.17% 76
2025
Q3
$208K Buy
737
+2
+0.3% +$580 0.15% 80
2025
Q2
$205K Buy
735
+2
+0.3% +$567 0.15% 83
2025
Q1
$228K Buy
733
+2
+0.3% +$591 0.18% 74
2024
Q4
$191K Buy
+731
New +$217K 0.15% 81

Other funds holding AMGN

Asset Planning Inc's AMGN Position: Q2 2026 in Review

Asset Planning Inc increased its Amgen (AMGN) stake by 0.27% in Q2 2026, buying an estimated $685 and bringing the position to 742 shares worth $269K. The position accounts for 0.17% of the portfolio, ranked #75.

Asset Planning Inc first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Asset Planning Inc held 742 shares of Amgen worth $269K as of Q2 2026.
  • Asset Planning Inc bought 2 Amgen shares in Q2 2026, an estimated $685.
  • Amgen made up 0.17% of Asset Planning Inc's portfolio in Q2 2026, its #75 holding.
  • Asset Planning Inc first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Asset Planning Inc's 13F filing for Q2 2026, filed 27 Jul 2026.